A relationship between the integrated assessment of magnetic resonance imaging markers for cerebral small vessel disease and the clinical and functional status in the acute period of ischemic stroke

Кулеш, А. А.; Кайлева, Н. А.; Горст, Н. Х.; Shestakov, V. V.

doi:10.14412/2074-2711-2018-1-24-31

Cited by 5 publications

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Long-term follow-up is necessary to recognize and assess the progression of cerebral atrophy. A case report of a patient with idiopathic dilated cardiomyopathy [33] , who was admitted to the hospital with dyspnea and leg edema, had an echocardiogram suggesting an ejection fraction of 36%, imaging studies suggesting decreased blood-cerebral blood flow, and clinical symptoms suggesting significant cognitive brain dysfunction. This implies that low cardiac output may directly contribute to systolic heart failure as well as total cerebral cerebral atrophy.Research has shown that patients with left ventricular hypertrophy accompanied by type 2 diabetes mellitus exhibit more pronounced amygdala atrophy compared to those without type 2 diabetes mellitus.…”

Section: Brain Atrophy and Left Ventricular Diseasementioning

confidence: 99%

Correlation of imaging markers of cerebral small vessel disease with left ventricular disease: A review

2023

medsc

View full text Add to dashboard Cite

Cerebral small vessel disease (CSVD) is a combination of disorders that affects the small arteries, veins, and microvessels of the brain. It can be observed on cranial magnetic resonance imaging as cerebral white matter hyperintensity, enlarged perivascular spaces, cerebral microbleeds, cerebral atrophy, and lacunes. The underlying mechanisms of cerebral small vessel disease remain unclear. Recent studies have suggested that left ventricle-associated diseases can contribute to a better understanding of the pathogenesis of cerebral small-vessel disease. Epidemiologic and clinicopathologic data have uncovered evidence of a relationship between cerebral small vessel disease and left ventricular disease. The purpose of this paper is to explore the complex relationship between cerebral small vessel disease and left ventricular disease. Defining the relationship between cerebral small vessel disease and left ventricular-related diseases is crucial for early prevention of cerebral small vessel disease.

show abstract

Section: Brain Atrophy and Left Ventricular Diseasementioning

confidence: 99%

Correlation of imaging markers of cerebral small vessel disease with left ventricular disease: A review

2023

medsc

View full text Add to dashboard Cite

show abstract

Hemorrhagic manifestations of cerebral amyloid angiopathy: from pathogenesis to clinical significance

Кулеш

Дробаха

Shestakov

2018

Nevrologiâ, nejropsihiatriâ, psihosomatika

Self Cite

View full text Add to dashboard Cite

The paper characterizes the neuropathological aspects of cerebral amyloid angiopathy (CAA) and its pathogenesis. It presents in detail the current neuroimaging markers of CAA and their neuropathological correlates. The phenotypic heterogeneity of the disease and its main clinical manifestations are considered; the updated Boston diagnostic criteria are formulated. The issues of intracerebral hemorrhages, cerebral microbleeding, and cortical superficial siderosis, which are associated with CAA, are elucidated in detail. CAA is noted to be of clinical significance for the determination of therapeutic policy in hemorrhagic stroke, systemic thrombolytic therapy, and cognitive impairment.

show abstract

Sporadic cerebral non-amyloid microangiopathy: pathogenesis, diagnosis, and features of treatment policy

Кулеш

Дробаха

Shestakov

2018

Nevrologiâ, nejropsihiatriâ, psihosomatika

Self Cite

View full text Add to dashboard Cite

В в е д е н и е «Церебральная болезнь мелких сосудов» (ЦБМС)термин, относящийся к различным патологическим состояниям и механизмам, которые приводят к поражению мелких сосудов белого и серого вещества головного мозга, и используемый для описания невропатологических, клинических и нейровизуализационных феноменов. ЦБМС является наиболее часто встречающимся патологическим процессом в неврологии и принимает участие в процессах старения, возникновения инсульта и деменции [1]. Современные достижения в понимании патогенеза ЦБМС основаны на клинико-патологических работах C.M. Fisher 1955-1973 гг. и связаны с активным развитием в последние годы метода магнитно-резонансной томографии (МРТ) [2, 3]. Трудности изучения ЦБМС объясняются невозможностью прижизненной визуализации мелких мозговых сосудов, частым практически бессимптомным течением заболевания и недостаточным внедрением унифицированных подходов к терминологии и диагностике. Основными проявлениями ЦБМС по данным МРТ служат лакунарные инфаркты (ЛИ), лакуны, гиперинтенсивность белого вещества (ГБВ), расширение периваскулярных пространств (ПВП), церебральные микроинфаркты (ЦМИ), а также внутримозговые кровоизлияния (ВМК) и церебральные микрокровоизлияния (ЦМК) [1]. С точки зрения патогенеза L. Pantoni [1, 2] классифицирует ЦБМС на 6 типов: 1) спорадическая неамилоидная микроангиопатия (СНАМА); 2) спорадическая и наследст-13

show abstract

A relationship between the integrated assessment of magnetic resonance imaging markers for cerebral small vessel disease and the clinical and functional status in the acute period of ischemic stroke

Cited by 5 publications

References 16 publications

Correlation of imaging markers of cerebral small vessel disease with left ventricular disease: A review

Correlation of imaging markers of cerebral small vessel disease with left ventricular disease: A review

Hemorrhagic manifestations of cerebral amyloid angiopathy: from pathogenesis to clinical significance

Sporadic cerebral non-amyloid microangiopathy: pathogenesis, diagnosis, and features of treatment policy

Contact Info

Product

Resources

About